USPTO trademark

TRIPTODUR CARE

AllowedUSPTOWord markClass 35Class 36Class 44Class 45

"TRIPTODUR CARE" is a word mark owned by Debiopharm International SA, filed at the USPTO on May 2, 2025. It has been allowed and covers classes 35, 36, 44 and 45.

Official USPTO record
TRIPTODUR CARE trademark as filed
As filed with the USPTO
Status
Allowed
Since June 16, 2026
Filed
May 2, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99167826
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns TRIPTODUR CARE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services TRIPTODUR CARE is filed for, grouped by Nice class.

  • Providing information relating to business administration guidance in the field of medication reimbursement programs and services

  • Providing information relating to patient support services in the nature of providing financial support to patients for the purpose of facilitating good health and affordability programs being financial administration of patient reimbursement programs, drug access, and financial administration guidance in the nature of medication reimbursement programs and services

  • Providing medical information relating to hormonal disorders and pharmaceuticals used to treat endocrine disorders indicated for the treatment of precocious puberty, in the nature of affordability programs being patient assistance programs to provide medicines at low or no cost to patients undergoing treatment for central precocious puberty, medicine access, and administration guidance

  • Providing information relating to patient support services in the nature of personal support services for patients, namely, emotional counseling and emotional support

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Teas/email correspondence entered
  7. Correspondence received in law office
  8. Teas response to office action received
  9. Application extension granted/receipt provided
  10. Application extension to response period - received

7 earlier steps on the official record.

FAQ

About TRIPTODUR CARE

Who owns the trademark "TRIPTODUR CARE"?

The USPTO trademark "TRIPTODUR CARE" (application 99167826) is owned by Debiopharm International SA.

What is the status of "TRIPTODUR CARE"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TRIPTODUR CARE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2abe-1448-72b5-8a72-c1168d24a6c8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2abe-1448-72b5-8a72-c1168d24a6c8",
  "object": "trademark",
  "mark_text": "TRIPTODUR CARE",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99167826",
  "filing_date": "2025-05-02",
  "nice_classes": [
    35,
    36,
    44,
    45
  ],
  "owners": [
    {
      "name": "Debiopharm International SA",
      "entity_id": "ent_019eb70b-6800-7238-b5b7-dbed47364f61"
    }
  ]
}